United States · FDA National Drug Code directory
Rozerem
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64764-805_2021e7fb-108a-4783-9a37-8bc05bf28b28
- Product NDC
- 64764-805
- Form
- TABLET, FILM COATED
- Composition / generic term
- ramelteon
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20050722
- Source listing expiry
- 20271231
Source-listed ingredients
- RAMELTEON — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (64764-805-10) · 64764-805-10
- 30 TABLET, FILM COATED in 1 BOTTLE (64764-805-30) · 64764-805-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →